The effect of particle size on cardiovascular disorders--the smaller the worse.

BACKGROUND Previous studies observed associations between airborne particles and cardio-vascular disease. Questions, however, remain as to which size of the inhalable particles (coarse, fine, or ultrafine) exerts the most significant impact on health. METHODS For this retrospective study, data of the total number of 23,741 emergency service calls, registered between February 2002 and January 2003 in the City of Leipzig, were analysed, identifying 5326 as being related to cardiovascular incidences. Simultaneous particle exposure was determined for the particle sizes classes <100 nm (UFP), <2.5 μm (PM2.5) and <10 μm (PM10). We used a time resolution of 1 day for both parameters, emergency calls and exposure. RESULTS Within the group of cardiovascular diseases, the diagnostic category of hypertensive crisis showed a significant association with particle exposure. The significant effect on hypertensive crisis was found for particles with a size of <100 nm in diameter and starting with a lag of 2 days after exposure. No consistent influence could be observed for PM2.5 and PM10. The Odds Ratios on hypertensive crisis were significant for the particle size <100 nm in diameter from day 2 post exposure OR=1.06 (95%CI: 1.02-1.10, p=0.002) up to day 7 OR=1.05 (95%CI 1.02-1.09, p=0.005). CONCLUSION Ultrafine particles affect cardiovascular disease adversely, particularly hypertensive crises. Their effect is significant compared with PM2.5 and PM10. It appears necessary, from a public health point of view, to consider regulating this type of particles using appropriate measurands as particle number.

[1]  O. Herbarth,et al.  Respiratory health, effects of ambient air pollution and its modification by air humidity in Drobeta-Turnu Severin, Romania. , 2009, The Science of the total environment.

[2]  J. Schwartz,et al.  Increased asthma medication use in association with ambient fine and ultrafine particles , 2002, European Respiratory Journal.

[3]  A. Peters,et al.  Particulate Matter Air Pollution and Cardiovascular Disease: An Update to the Scientific Statement From the American Heart Association , 2010, Circulation.

[4]  H. Wichmann,et al.  Long-term measurements of size-segregated ambient aerosol in two German cities located 100 km apart , 2003 .

[5]  J D Kaufman,et al.  Cardiovascular Disease and Air Pollutants: Evaluating and Improving Epidemiological Data Implicating Traffic Exposure , 2007, Inhalation toxicology.

[6]  Barbara Thorand,et al.  Cardiovascular effects of fine and ultrafine particles. , 2005, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[7]  Nelson Gouveia,et al.  The avoidable health effects of air pollution in three Latin American cities: Santiago, São Paulo, and Mexico City. , 2006, Environmental research.

[8]  T. Sandström,et al.  Adverse cardiovascular effects of air pollution , 2009, Nature Clinical Practice Cardiovascular Medicine.

[9]  A. Peters,et al.  Size-Segregated Particle Number Concentrations and Respiratory Emergency Room Visits in Beijing, China , 2010, Environmental health perspectives.

[10]  A. Peters,et al.  Effects of air pollution on blood pressure: a population-based approach. , 2001, American journal of public health.

[11]  A. Peters,et al.  Weak correlation of ultrafine aerosol particle concentrations <800 nm between two sites within one city , 2006, Journal of Exposure Science and Environmental Epidemiology.

[12]  Peter Höppe,et al.  Health effects of particles in ambient air. , 2004, International journal of hygiene and environmental health.

[13]  A. Wiedensohler,et al.  Long term measurements of submicrometer urban aerosols: statistical analysis for correlations with meteorological conditions and trace gases , 2002 .

[14]  O. Herbarth Risk assessment of environmentally influenced airway diseases based on time-series analysis. , 1995, Environmental health perspectives.

[15]  T. Tuch,et al.  Indoor and outdoor submicrometer particles: Exposure and epidemiologic relevance (“the 3 indoor Ls”) , 2006, Environmental toxicology.

[16]  S. Médina,et al.  Apheis: Health Impact Assessment of Long-term Exposure to PM2.5 in 23 European Cities , 2006, European Journal of Epidemiology.

[17]  Qinghua Sun,et al.  Contemporary Reviews in Cardiovascular Medicine Cardiovascular Effects of Ambient Particulate Air Pollution Exposure , 2010 .

[18]  Robert D Brook,et al.  Is air pollution a cause of cardiovascular disease? Updated review and controversies , 2007, Reviews on environmental health.

[19]  J Pekkanen,et al.  Effects of fine and ultrafine particles on cardiorespiratory symptoms in elderly subjects with coronary heart disease: the ULTRA study. , 2003, American journal of epidemiology.

[20]  A. Peters,et al.  Particulate air pollution and nonfatal cardiac events. Part I. Air pollution, personal activities, and onset of myocardial infarction in a case-crossover study. , 2005, Research report.

[21]  O. Raaschou-Nielsen,et al.  Size distribution and total number concentration of ultrafine and accumulation mode particles and hospital admissions in children and the elderly in Copenhagen, Denmark , 2007, Occupational and Environmental Medicine.

[22]  R. Kloner,et al.  Particulate air pollution and coronary heart disease , 2009, Current opinion in cardiology.

[23]  Ali S. Kamal,et al.  Insights Into the Mechanisms and Mediators of the Effects of Air Pollution Exposure on Blood Pressure and Vascular Function in Healthy Humans , 2009, Hypertension.

[24]  A Plasencia,et al.  Apheis: public health impact of PM10 in 19 European cities , 2004, Journal of Epidemiology and Community Health.

[25]  W G Kreyling,et al.  Daily mortality and fine and ultrafine particles in Erfurt, Germany part I: role of particle number and particle mass. , 2000, Research report.